Question Your Understanding of MH: The anesthesia community has the best understanding of Malignant Hyperthermia [MH] because it is a genetically determined illness that is most often recognized during or…
Methylene blue is administered intravenously by anesthesia providers for a variety of clinical uses and may be used with increasing frequency as an intraoperative urologic marker dye due to an…
Adoption of Anesthesia Information Management Systems (AIMS) continues to accelerate. It is estimated that 75% of US academic anesthesiology departments are using an AIMS and that this will rise to…
INTRODUCTION Anesthesia providers participate in patient handoffs several times for each patient under their care. Each handoff has the potential for poor communication that may jeopardize patient safety. In fact,…
To the Editor: Airway suctioning is usually performed by introducing a suction catheter into the endotracheal tube after disconnecting the patient from the ventilator. It can also be accomplished with…
Letter to the Editor: To the Editor: The APSF Newsletter in February 2015 carried a piece on drug shortages (“Drug Shortages in the U.S. – A Balanced Perspective”). It seems…
SECTION EDITOR, PATIENT SAFETY The Anesthesia Patient Safety Foundation (APSF) is pleased to invite applications for Section Editor, Patient Safety, Anesthesia & Analgesia, to begin January 1, 2016. Anesthesia &…
The Anesthesia Patient Safety Foundation gratefully acknowledges an educational grant from www.merck.com to support the June 2015 issue of the APSF Newsletter
Visit the APSF website (www.apsf.org) to view the following DVDs and request a complimentary copy.
The Official Journal of the Anesthesia Patient Safety Foundation
The Anesthesia Patient Safety Foundation Newsletter is the official publication of the nonprofit Anesthesia Patient Safety Foundation and is published three times per year in Wilmington, Delaware. Individual subscription–$100, Corporate–$500. Contributions to the Foundation are tax deductible. ©Copyright, Anesthesia Patient Safety Foundation, 2015.
The opinions expressed in this Newsletter are not necessarily those of the Anesthesia Patient Safety Foundation. The APSF neither writes nor promulgates standards, and the opinions expressed herein should not be construed to constitute practice standards or practice parameters. Validity of opinions presented, drug dosages, accuracy, and completeness of content are not guaranteed by the APSF.
Robert K. Stoelting, MD, President; Jeffrey B. Cooper, PhD, Executive Vice President; George A. Schapiro, Executive Vice President; Robert J. White, Vice President; Matthew B. Weinger, MD, Secretary; Casey D. Blitt, MD, Treasurer; Sorin J. Brull, MD; Robert A. Caplan, MD; David M. Gaba, MD; Steven K. Howard, MD; Lorri A. Lee, MD; Robert C. Morell, MD; A. William Paulsen, PhD; Richard C. Prielipp, MD; Steven R. Sanford, JD; Maria A. van Pelt, CRNA; Mark A. Warner, MD. Consultants to the Executive Committee: John H. Eichhorn, MD; Bruce P. Hallbert, PhD.
Robert C. Morell, MD, Co-Editor; Lorri A. Lee, MD, Co-Editor; Steven B. Greenberg, MD, Assistant Editor; Sorin J. Brull, MD; Joan Christie, MD; Jan Ehrenwerth, MD; John H. Eichhorn, MD; Glenn S. Murphy, MD; John O’Donnell, DrPH, CRNA; Wilson Somerville, PhD; Jeffery Vender, MD.
Issue PDF